Skip to main content

Table 2 Estimated costs of genital herpes in the USA (physicians' study)

From: The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

  Costs (in % of direct costs % of total costs
  thousands US$)   
Consultations/lab testing (n)    
First episodes (422,950) 74,016   
1 to 2 (104,150) 19,684   
3 to 6 (468,650) 265,725   
7 or more (124,970) 110,224   
Subtotal 469,649 47.7%  
Drugs (n)    
First episodes (422,950) 27,069   
1 to 2 (104,150) 20,465   
3 to 6 (468,650) 303,685   
7 or more (124,970) 137,342   
Subtotal 488,561 49.7%  
Hospital (n)    
First episodes (422,950) 424   
1 to 2 (104,150) 1,250   
3 to 6 (468,650) 16,871   
7 or more (124,970) 6,998   
Subtotal 25,543 2.6%  
Total direct costs (n)    
First episodes (422,950) 101,508   
1 to 2 (104,150) 41,400   
3 to 6 (468,650) 586,281   
7 or more (124,970) 254,654   
Total 983,843 100% 82.1%
Total indirect costs (n)    
First episodes (422,950) 25,377   
1 to 2 (104,150) 9,373   
3 to 6 (468,650) 126,536   
7 or more (124,970) 52,487   
Total 213,773   17.9%
Total direct plus indirect costs    
First episodes (422,950) 126,885   
1 to 2 (104,150) 50,773   
3 to 6 (468,650) 712,817   
7 or more (124,970) 307,051   
  1,197,526   100%
  1. Note: Costs are expressed in 1996 US$.